X0206 3 2023-06-01 0 0001601485 Elicio Therapeutics, Inc. ELTX 0001979163 DeMuth Peter C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210 true Chief Scientific Officer Stock Option (right to buy) 4.42 2027-12-27 Common Stock 181 D Stock Option (right to buy) 4.42 2025-12-10 Common Stock 362 D Stock Option (right to buy) 4.42 2026-11-04 Common Stock 362 D Stock Option (right to buy) 4.42 2024-12-18 Common Stock 381 D Stock Option (right to buy) 13.81 2032-03-31 Common Stock 14479 D Stock Option (right to buy) 4.42 2028-03-20 Common Stock 814 D Stock Option (right to buy) 12.71 2031-02-26 Common Stock 905 D Stock Option (right to buy) 4.42 2027-10-02 Common Stock 1448 D Stock Option (right to buy) 9.94 2028-10-12 Common Stock 2476 D Stock Option (right to buy) 9.39 2030-03-24 Common Stock 8145 D Stock Option (right to buy) 3.87 2032-11-28 Common Stock 60746 D Shares of capital stock of the corporation then known as Elicio Therapeutics, Inc. ("Old Elicio") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 17, 2023, by and among the Issuer, Arkham Merger Sub, Inc. and Old Elicio (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of capital stock was exchanged for 0.0181 shares of the Issuer's common stock, giving effect to a reverse split of the Issuer's common stock of 10-to-1. Represents 181 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 362 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 362 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 381 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 14,479 stock options granted under the Issuer's 2012 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of March 23, 2022 with the remaining options vesting in monthly installments over a three-year period thereafter. Represents 814 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 905 stock options granted under the Issuer's 2012 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of February 26, 2021 with the remaining options vesting in monthly installments over a three-year period thereafter. Represents 1,448 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 2,476 stock options granted under the Issuer's 2012 Equity Incentive Plan. The stock options are fully vested. Represents 8,145 stock options granted under the Issuer's 2012 Equity Incentive Plan. Twenty five percent (25%) of the stock options vest on the one-year anniversary of March 24, 2022 with the remaining options vesting in monthly installments over a three-year period thereafter. Represents 60,746 stock options granted under the Issuer's 2012 Equity Incentive Plan. The options vest in equal monthly installments over three years, beginning of November 28, 2022. Exhibit 24.1 - Power of Attorney. /s/ Nishant M. Dharia, Attorney-in-fact 2023-06-07